Detalhe da pesquisa
1.
Ebola virus antibody decay-stimulation in a high proportion of survivors.
Nature
; 590(7846): 468-472, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505020
2.
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152053
3.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220855
4.
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(1): 189-196, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493541
5.
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.
Blood
; 130(1): 48-58, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490572
6.
A Case of Cardiac Arrhythmia from Absorption of Normal Saline during Hysteroscopic Myomectomy.
J Minim Invasive Gynecol
; 26(4): 770-773, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267897
7.
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 19(7): 889-903, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859851
8.
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.
Transfusion
; 58(5): 1289-1298, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572862
9.
The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib.
Am J Hematol
; 98(12): E364-E368, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815132
10.
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
Nature
; 485(7397): 260-3, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22504184
11.
Roman warfare: targeting of support cells in AML.
Blood
; 133(6): 506-507, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733203
12.
The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.
Haematologica
; 106(8): 2242-2245, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626861
13.
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
Blood
; 121(16): 3165-71, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23430109
14.
Association of age-dependent liver injury and fibrosis with immune cell populations.
Liver Int
; 33(8): 1175-86, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23710620
15.
FLT3 targeting in the modern era: from clonal selection to combination therapies.
Int J Hematol
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112995
16.
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
J Geriatr Oncol
; 14(8): 101623, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678052
17.
Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification.
bioRxiv
; 2023 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292835
18.
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.
Cell Rep Med
; 4(11): 101290, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992684
19.
Microfluidics-free single-cell genomics with templated emulsification.
Nat Biotechnol
; 41(11): 1557-1566, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879006
20.
Structural surfaceomics reveals an AML-specific conformation of integrin ß2 as a CAR T cellular therapy target.
Nat Cancer
; 4(11): 1592-1609, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904046